Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03657615
Other study ID # USaoPauloCF
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 15, 2014
Est. completion date June 30, 2019

Study information

Verified date July 2018
Source University of Sao Paulo General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Using resting state positron emission tomography (PET), our goal was to analyze the metabolic and functional neural changes that occur after 6 months of effective hearing aid (HA) use. Besides, we correlate those changes with behavioral results. Patients with chronic tinnitus and untreated sensorineural hearing loss were tested pre-HA fitting, and at 6 months post-HA fitting.


Description:

Subjects are selected as they are enrolled in the Tinnitus Research Group between January 2014 and September 2018. The study was approved by the local medical ethics committee for research at the Medical School of University of São Paulo - protocol number 611.174 in April, 2014.

All the procedures were performed after medical evaluation and a complete tinnitus evaluation protocol, which included somatosensory assessment, self-related questionnaires for tinnitus and hearing: Tinnitus Handicap Inventory (THI), Hearing Handicap Inventory for Adults (HHIA), and , for anxiety and depression symptoms: Generalized Anxiety Depression Scale (GAD-7) and Patient Health Questionnaire (PHQ-9), and for neck pain (Neck Disability Index, NDI). The subjects of this study were also blood tested for pregnancy and diabetes, which may interfere on fluorodeoxyglucose (FDG)-positron emission tomography PET acquisition.

All subjects underwent hearing and tinnitus evaluation, counseling and hearing aid fitting.

To prescribe and verify acoustic response, we used the HA fitting protocol recommended by the National Acoustics Laboratories (NAL), named NAL NL-2 (NL-non linear) FDG-PET measurements were obtained at baseline (prior to HA fitting) and after 6 months of HA use.

Regarding FDG-PET images, a within-subject analysis was performed by comparing pre-treatment and post-treatment group using paired-t-tests.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date June 30, 2019
Est. primary completion date September 30, 2018
Accepts healthy volunteers No
Gender All
Age group 32 Years to 62 Years
Eligibility Inclusion Criteria::

1. chronic perception of tinnitus for more than 6 months;

2. THI score greater than 38;

3. bilateral and symmetric hearing loss not exceeding 70 decibels (dB) hearing threshold;

4. no previous experience with HA. -

Exclusion Criteria:

1. unilateral, mixed or conductive hearing loss;

2. pulsatile or myoclonic tinnitus;;

3. anxiety and depression detected by GAD-7 and PHQ-9;

4. significant visual, motor or cognitive deficits;

5. pregnant women and diabetic patients

6. history of drug abuse -

Study Design


Related Conditions & MeSH terms


Intervention

Device:
hearing aid fitting
All patients were fitted bilaterally with hearing aids for hearing loss compensation. . Apart from different HAs used, device selection followed strict criteria to fit hearing loss demands, patient profile, resources and algorithms recommended for tinnitus patients.

Locations

Country Name City State
Brazil University of Sao Paulo São Paulo Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo General Hospital

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary PET RESULTS After an individual whole brain analysis, a within-subject analysis was performed by comparing pre-treatment and post-treatment situation. The analysis revealed increased and decreased glycolytic metabolism areas for each subject, after intervention. For group analysis we used paired-t-tests. These analyses produced parametric statistical maps, which were then converted into a normal distribution unit (Z-scores). The significance threshold was set at p<0.05, and corrected for multiple comparisons (FWE or family-wise error rate), either at the voxel or cluster-level. 6 months
Secondary Tinnitus Handicap Inventory (THI) The THI consists of 25 questions distributed on three scales that evaluate different tinnitus aspects: functional, emotional and catastrophic. The options for responding to THI questions are: yes (4 points), sometimes (2 points), and no (0 points). On a scale from 0-100, 0-16 points signifies negligible tinnitus, 18-36 signifies mild tinnitus, 38-56 signifies moderate tinnitus, 58-76 signifies severe tinnitus, and 78-100 signifies catastrophic tinnitus. Reductions on scale signifies tinnitus perception are reduced.Results of self-assessment questionnaires and their respective subscales were described according to the follow up evaluation moment. They were all analyzed statistically. 6 months
Secondary Hearing Handicap Inventory for Adults (HHIA) Composed of 25 questions that evaluate social and emotional aspects of hearing disability. Subjects had three choices: yes (4 points), sometimes (2 points) and no (0 points). On a scale from zero to 100, scores higher than 44 points indicate severe handicap, from 18-42 points indicate moderate handicap and below 18 indicate no handicap. After intervention, reductions on scale means less hearing handicap.Results of self-assessment questionnaires and their respective subscales were described according to the follow up evaluation moment. They were all analyzed statistically. 6 months
Secondary Visual Analog Scale ( VAS) The VAS is a numeric scale ranging from 0-10. Subjects assigned a value to tinnitus annoyance based on this visual scale. High scores means high degree of tinnitus annoyance.Results were described according to the follow up evaluation moment. and then analyzed statistically. 6 months
See also
  Status Clinical Trial Phase
Completed NCT01965028 - Daily Bi-temporal Transcranial Random Noise Stimulation in Tinnitus N/A
Completed NCT03550430 - Neurofeedback for Tinnitus - Does Frequency Specificity Matter? N/A
Recruiting NCT02615600 - Daily Bitemporal Low-frequency Transcranial Random Noise Stimulation in Tinnitus (tRNS2-tin) N/A
Completed NCT01540357 - Mindfulness-based Therapy in Chronic Tinnitus N/A
Completed NCT01407133 - Conventional Repetitive Transcranial Magnetic Stimulation for Tinnitus Treatment Phase 1/Phase 2
Completed NCT02508220 - Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus N/A
Completed NCT01907022 - Combined rTMS and Relaxation in Chronic Tinnitus N/A
Completed NCT01663311 - Repetitive Transcranial Magnetic Stimulation With Double Cone Coil in Chronic Tinnitus N/A
Completed NCT01663324 - rTMS for the Treatment of Chronic Tinnitus: Optimization by Simulation of the Cortical Tinnitus Network N/A
Completed NCT02653547 - Influence of Treatment Duration and Stimulation Frequency on rTMS in Chronic Tinnitus N/A
Completed NCT02199106 - Effectiveness of Neuronavigated Continuous Theta Burst Stimulation of the Left Heschl's Gyrus in Chronic Tinnitus N/A
Completed NCT02306447 - Combined Transcranial and Peripheral Muscle Magnetic Stimulation in Chronic Tinnitus N/A